Skip to main content
Livermore
Livermore
ZHEN

Janus Henderson Group PLC

SEC CIK
0001274173
Latest filing
May 18, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by Janus Henderson Group PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q1 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of AKRO by Janus Henderson Group PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−6,280,305−100.0%Sold outHolders
Q3 20256,280,305$298.2M0.1%−458,251−6.8%ReducedHolders
Q2 20256,738,556$359.5M0.2%−330,092−4.7%ReducedHolders
Q1 20257,068,648$301.9M0.2%+1,034,409+17.1%AddedHolders
Q4 20246,034,239$167.8M0.1%−1,043,239−14.7%ReducedHolders
Q3 20247,077,478$203.1M0.1%+201,225+2.9%AddedHolders
Q2 20246,876,253$161.3M0.1%+754,283+12.3%AddedHolders
Q1 20246,121,970$154.6M0.1%+1,815,569+42.2%AddedHolders
Q4 20234,306,401$100.6M0.1%−180,325−4.0%ReducedHolders
Q3 20234,486,726$227.0M0.1%+61,607+1.4%AddedHolders
Q2 20234,425,119$206.6M0.1%+613,443+16.1%AddedHolders
Q1 20233,811,676$145.8M0.1%+471,502+14.1%AddedHolders
Q4 20223,340,174$183.0M0.1%−935,285−21.9%ReducedHolders
Q3 20224,275,459$145.6M0.1%+1,207,147+39.3%AddedHolders
Q2 20223,068,312$29.0M<0.1%−300,350−8.9%ReducedHolders
Q1 20223,368,662$47.8M<0.1%+205,040+6.5%AddedHolders
Q4 20213,163,622$66.9M<0.1%−71,365−2.2%ReducedHolders
Q3 20213,234,987$72.3M<0.1%−252,508−7.2%ReducedHolders
Q2 20213,487,495$86.5M<0.1%+4,830+0.1%AddedHolders
Q1 20213,482,665$101.0M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.